Is interleukin 2 the best initial therapy for many patients with metastatic renal cell carcinoma?

Cancer J. 2013 May-Jun;19(3):197-8. doi: 10.1097/PPO.0b013e318292e6a2.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Agents / administration & dosage*
  • Carcinoma, Renal Cell / drug therapy*
  • Female
  • Humans
  • Interleukin-2 / administration & dosage*
  • Kidney Neoplasms / drug therapy*
  • Male

Substances

  • Antineoplastic Agents
  • Interleukin-2